CVS/pharmacy is launching initiatives this month aimed at fighting prescription-drug abuse.Among these efforts is increasing the availability of the opioid-overdose reversal medicine naloxone in several states. Read More »

The U.S. Food and Drug Administration (FDA) recently approved Lonsurf, a drug for people who have an advanced form of colorectal cancer. Read More »

The U.S. Food and Drug Administration (FDA) recently agreed to review a New Drug Application (NDA) for Vesneo, an intraocular pressure-lowering, single-agent eye drop used once daily. Read More »

Problems with the Texas State Board of Pharmacy's operating procedures were uncovered recently by the State Auditor's Office (SAO).The Board of Pharmacy is charged with the inspection of all compounding pharmacies in the state to be sure they are complying with all laws and regulations. Read More »

Results released this week from a study conducted by CVS Health Research Institute and Brigham and Women's Hospital researchers indicated that a patient's future medication-adherence behavior can be predicted by examining the patient's patterns of medication fills in the first few months after beginning chronic therapy. Read More »

Specialty pharmaceutical company Akorn, Inc. said Monday it has added Doxercalciferol Injection Solution in single-use vials to its product line. Doxercalciferol Injection is used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Read More »

Steven Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), weighed in on the House Ways and Means Committee’s recent passage of the Restoring Access to Medication Act of 2015 (H.R. 1270). Read More »

The National Community Pharmacists Association (NCPA) and International Academy of Compounding Pharmacists (IACP) have praised 31 U.S. House lawmakers who recently protested a policy change that drastically has reduced coverage for customized, or compounded, prescription medications in the Department of Defense's (DOD) TRICARE health care program. Read More »

Democratic presidential hopeful Hillary Rodham Clinton said this week that she would target excessive profiteering and marketing costs in the pharmaceuticals industry by encouraging innovation and new treatments from drug companies, if she were elected. Read More »

Health and Human Services Secretary Sylvia Burwell said this week that the agency would provide nearly $500 million in Affordable Care Act funds to aid health centers across the nation that provide primary-care services to those in need. Read More »

The Texas State Auditor's Office (SAO) recently said it found problems with the Texas State Board of Pharmacy's operating procedures. It is the responsibility of the Board of Pharmacy to inspect all compounding pharmacies in the state to be sure they are complying with all laws and regulations. Read More »

An analysis of data by the American Pharmacy News indicates that Iowa’s pharmacy business has largely weathered the economic storm and remains strongly local, home-grown and vibrant. Read More »

In response to the price for one prescription drug increasing by 5,000 percent as its demand for treatment of a common parasite that attacks people with weakened immune systems has grown, some health experts who treat patients with AIDS and cancer have denounced the new cost to treat a condition could be life-threatening. Read More »

The Center for American Progress has put forward a proposal to make changes within Medicare aimed at helping users, including instituting consumer-friendly ratings of the benefits new drugs may have, limiting what patients must pay for new drugs and requiring pharmaceutical companies to disclose how much is actually spent on researching and bringing new drugs to market, the Associated Press said. Read More »

Vraylar proven to be effective in treating both mental health issues during extensive clinical trials. Read More »

The recent approval by the U.S. Food and Drug Administration of Merck’s pediatric EMEND (aprepitant) capsules means that young cancer patients undergoing chemotherapy won’t have to suffer some of the side effects commonly associated with the disease. Read More »

Xerox recently began working with MO HealthNet, Missouri’s state Medicaid division, to tackle the prescription-opioid drug abuse epidemic by using technology that increases the communication between physicians and pharmacists to ensure that opioids are prescribed and used safely. Read More »

Trxade Group, a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, said on Thursday that Paragon Meds, a national pharmaceutical wholesale distributor, has joined Trxade’s trading marketplace as its newest Trxade supplier partner. Read More »

Cardinal Health is offering eHealth's Medicare plan comparison tool and the iMedicare platform to its retail pharmacy customers so they can easily compare Medicare Part D prescription drug plans. The new online offerings arrive ahead of the open enrollment period, which starts in the middle of October and runs through Dec. 7. Read More »

The annual American Pharmacy Association-led Pharmacy Section at the Utah School, which educates pharmacists and student pharmacists on the dangers of addiction, returned to Salt Lake City in June under a new name, the APhA Institute on Alcoholism and Drug Dependencies, after the Utah School's closure last year. Read More »